Pneumocystis jirovecii pneumonia (PJP) is the most common fungal pneumonia in children. But current diagnostic methods can take days an require an invasive bronchoscopy procedure. Now, a new ...
The sequence contained a promising new genetic tool for modifying DNA, a CRISPR. Editas Medicine, a Massachusetts-based ...
CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...
Where some saw an imperfect compromise, other attendees apparently left the talks in disgust. In published reports, for ...
Antibiotic resistance is a global concern that threatens our ability to prevent and treat bacterial infections in humans and animals.
Gene editing techniques may eventually allow for trisomy disorders to be treated at the cellular level, according to an in ...
Antibiotic resistance is a global concern that threatens our ability to prevent and treat bacterial infections in humans and ...
A research team at the University of Cologne has made a significant breakthrough in understanding the role of the tau protein ...
Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Intellia's technology platform specializes in Clustered Regularly Interspaced Short ...
A vast search of natural diversity has led scientists at MIT's McGovern Institute and the Broad Institute of MIT and Harvard ...
The strange world of organ preservation is spawning new tech firms. OrganOx has added impetus to the industry with a $142mn ...
CAMBRIDGE, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback